litlas
ログインアカウント作成

Robert J. Fox

1979–2025 年に発表

別表記
Robert J Fox
111
論文数
19,639
被引用数
64
h 指数
105
i10 指数

被引用数

Robert J. Fox の年別被引用数1973 年: 被引用 2 件1981 年: 被引用 2 件1983 年: 被引用 2 件1987 年: 被引用 1 件1990 年: 被引用 2 件1991 年: 被引用 1 件1992 年: 被引用 9 件1993 年: 被引用 10 件1994 年: 被引用 15 件1995 年: 被引用 17 件1996 年: 被引用 11 件1997 年: 被引用 19 件1998 年: 被引用 21 件1999 年: 被引用 16 件2000 年: 被引用 21 件2001 年: 被引用 24 件2002 年: 被引用 20 件2003 年: 被引用 24 件2004 年: 被引用 17 件2005 年: 被引用 15 件2006 年: 被引用 28 件2007 年: 被引用 41 件2008 年: 被引用 74 件2009 年: 被引用 109 件2010 年: 被引用 131 件2011 年: 被引用 110 件2012 年: 被引用 103 件2013 年: 被引用 128 件2014 年: 被引用 149 件2015 年: 被引用 216 件2016 年: 被引用 158 件2017 年: 被引用 205 件2018 年: 被引用 210 件2019 年: 被引用 792 件2020 年: 被引用 861 件2021 年: 被引用 911 件2022 年: 被引用 852 件2023 年: 被引用 482 件2024 年: 被引用 803 件2025 年: 被引用 397 件2026 年: 被引用 6 件1974〜1980 年は被引用が無いため表示していません1982 年は被引用が無いため表示していません1984〜1986 年は被引用が無いため表示していません1988〜1989 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,143 件、この内訳の 22.4%ドイツ: 引用元論文 818 件、この内訳の 8.6%イタリア: 引用元論文 736 件、この内訳の 7.7%イギリス: 引用元論文 728 件、この内訳の 7.6%カナダ: 引用元論文 514 件、この内訳の 5.4%スイス: 引用元論文 369 件、この内訳の 3.9%フランス: 引用元論文 339 件、この内訳の 3.6%オランダ: 引用元論文 339 件、この内訳の 3.5%スペイン: 引用元論文 330 件、この内訳の 3.5%オーストラリア: 引用元論文 329 件、この内訳の 3.4%中国: 引用元論文 294 件、この内訳の 3.1%オーストリア: 引用元論文 204 件、この内訳の 2.1%
0%22.4%その他 25.2%

機関

分野

  • Medicine66.5%
  • Biochemistry, Genetics and Molecular Biology12.3%
  • Neuroscience12.1%
  • Immunology and Microbiology5.7%
  • Health Professions1.1%
  • Psychology0.4%
  • その他1.9%

トピック

  • Multiple Sclerosis Research Studies19.3%
  • Peripheral Neuropathies and Disorders5.3%
  • Neuroinflammation and Neurodegeneration Mechanisms4.7%
  • Neurogenesis and neuroplasticity mechanisms2.8%
  • Polyomavirus and related diseases2.8%
  • Immunotherapy and Immune Responses2.1%
  • その他63%

共著者

全論文

検索で開く
  1. Defining the clinical course of multiple sclerosis

    著者: Fred Lublin, Stephen C. Reingold, Jeffrey A. Cohen, Gary Cutter, Per Soelberg Sørensen, Alan J. Thompson, Jerry S. Wolinsky, Laura J. Balcer, Brenda Banwell, Frederik Barkhof, Bruce F. Bebo, Peter A. Calabresi, Michel Clanet, Giancarlo Comi, Robert J. Fox, Mark S. Freedman, Andrew Goodman, Matilde Inglese, Ludwig Kappos, Bernd C. Kieseier, John A. Lincoln, Catherine Lubetzki, Aaron E. Miller, Xavier Montalbán, Paul O’Connor, John Petkau, Carlo Pozzilli, Richard A. Rudick, Maria Pia Sormani, Olaf Stüve, Emmanuelle Waubant, Chris H. Polman - Neurology 2014 被引用: 3,133

  2. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

    著者: Ludwig Kappos, Amit Bar‐Or, Bruce Cree, Robert J. Fox, Gavin Giovannoni, Ralf Gold, Patrick Vermersch, Douglas L. Arnold, Sophie Arnould, Tatiana Scherz, Christian Wolf, Erik Wallström, Frank Dahlke, Anat Achiron, Lutz Achtnichts, Kadriye Ağan, Gülşen Akman‐Demir, Alison Allen, Jack P. Antel, Alfredo Rodríguez Antigüedad, Michelle Apperson, Angela Applebee, Guillermo Izquierdo Ayuso, Masayuki Baba, Ovidiu Băjenaru, Rodica Balasa, Belgin Petek Balcı, Michael Barnett, Ann Bass, V. Becker, Mihaela Bejinariu, Florian Then Bergh, Arnfin Bergmann, Evanthia Bernitsas, Achim Berthele, Virender Bhan, Felix Bischof, Randall J. Bjork, Gregg Blevins, Matthias Boehringer, Thomas Boerner, Robert Bonek, James D. Bowen, Allen C. Bowling, Alexey Boyко, Cavit Boz, Vera Bracknies, Stefan Braune, Vincenzo Brescia Morra, Bruno Brochet, Waldemar Brola, Paul Brownstone, M Brozman, Donald Brunet, Ioan Buraga, Margaret Burnett, Mathias Buttmann, Helmut Butzkueven, Jonathan Cahill, Jonathan Calkwood, William Camu, Mark Cascione, G. Castelnovo, Diego Centonze, João Cerqueira, Andrew Chan, Andrea Cimprichová, Stanley Cohan, Giancarlo Comi, Jill Ker Conway, Joanna A. Cooper, John R. Corboy, Jorge Correale, Brian Costell, David A. Cottrell, Patricia K. Coyle, Matthew Craner, Liying Cui, Luı́s Cunha, Anna Członkowska, Ana Silva, Joao de, de Sèze, Marc Debouverie, Jan Debruyne, D. Decoo, G. Defer, Tobias Derfuß, Norma Deri, Bhupesh Dihenia, Péter Diószeghy, Vladimír Donáth, Bénédicte Dubois, Martin Duddy, Pierre Duquette, Gilles Edan, Hüsnü Efendi, Stanton B. Elias, Peter Emrich, Bonaventura Casanova Estruch ほか 228 名 - The Lancet 2018 被引用: 925

  3. B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

    著者: Stephen L. Hauser, Emmanuelle Waubant, Douglas L. Arnold, Timothy R. Vollmer, Jack P. Antel, Robert J. Fox, Amit Bar‐Or, Michael Panzara, Neena Sarkar, Sunil Agarwal, Annette Langer‐Gould, Craig H. Smith - New England Journal of Medicine 2008 被引用: 2,399

  4. Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial

    著者: Daniel S. Reich, Douglas L. Arnold, Patrick Vermersch, Amit Bar‐Or, Robert J. Fox, André Palma da Cunha Matta, Timothy J. Turner, Erik Wallström, Xinyan Zhang, Miroslav Mareš, Ф. А. Хабиров, Anthony Traboulsee, François Grand’Maison, François Jacques, Anthony Traboulsee, Michaela Týblová, Eva Meluzínová, Radek Ampapa, Martin Vališ, Pavel Hradilke, Miroslav Mareš, Pavel Štourač, Katrin Gross‐Paju, David Laplaud, Guillaume Mathey, Bernard M.J. Uitdehaag, Evgeny Evdoshenkoo, Е. В. Попова, Maria Zakharova, N. А. Totolyan, И. В. Литвиненко, Ф. А. Хабиров, С А Сиверцева, Viera Hančinová, Ema Kantorová, María Luisa Martínez Ginés, Xavier Montalbán, Sara Eichau Maduano, José Meca-Lallana, Lluís Ramió‐Torrentà, Tetyanna Nehrych, V.M. Pashkovskyy, Sergii Moskovko, O. I. Kalbus, Marta Khavunka, Volodymyr Pryshchepa, Alla Goloborodko, Daniel Wynn, William Honeycutt, Sibyl Wray, Brian Steingo, Christopher LaGanke, DeRen Huang, John M. Hemphill, Lawrence Goldstick, Derrick Robertson - The Lancet Neurology 2021 被引用: 192

  5. Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

    著者: Robert J. Fox, David H. Miller, J. Theodore Phillips, Michael Hutchinson, Eva Havrdová, Mariko Kita, Minhua Yang, Kartik Raghupathi, Mark Novas, Marianne T. Sweetser, Vissia Viglietta, Katherine Dawson - New England Journal of Medicine 2012 被引用: 1,332

  6. Secondary Progressive Multiple Sclerosis

    著者: Bruce Cree, Douglas L. Arnold, Jeremy Chataway, Tanuja Chitnis, Robert J. Fox, Angela Pozo Ramajo, Niamh Murphy, Hans Lassmann - Neurology 2021 被引用: 252

  7. Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial

    著者: John R. Corboy, Robert J. Fox, Ilya Kister, Gary Cutter, Charity J. Morgan, Rebecca Seale, Eric Engebretson, Tarah Gustafson, Aaron E. Miller, Dennis Bourdette, Vijayshree Yadav, Andrew Goodman, Michael K. Racke, Robert J. Fallis, Carlo Tornatore, Myla Goldman, Meena Kannan, Subramaniam Sriram, Joseph R. Berger, Anne H. Cross, Kottil Rammohan, Zongqi Xia, Thomas Leist, Sharon Lynch, Eric C. Klawiter, Lilyana Amezcua, James D. Bowen - The Lancet Neurology 2023 被引用: 136

  8. Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study

    著者: Ludwig Kappos, Robert J. Fox, Michel Burcklen, Mark S. Freedman, Eva Havrdová, Bryan T. Hennessy, Reinhard Hohlfeld, Fred Lublin, Xavier Montalbán, Carlo Pozzilli, Tatiana Scherz, Daniele D’Ambrosio, Philippe Linscheid, Andrea Vaclavkova, Magdalena Pirozek-Lawniczek, Hilke Kracker, Till Sprenger - JAMA Neurology 2021 被引用: 218

  9. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients

    著者: Ranjan Dutta, Jennifer McDonough, Xinghua Yin, John W. Peterson, Ansi Chang, Thalia Torres, Tatyana I. Gudz, Wendy B. Macklin, David A. Lewis, Robert J. Fox, Richard A. Rudick, Károly Mirnics, Bruce D. Trapp - Annals of Neurology 2006 被引用: 832

  10. Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis

    著者: Robert J. Fox, Christopher S. Coffey, Robin Conwit, Merit Cudkowicz, Trevis Gleason, Andrew Goodman, Eric C. Klawiter, Kazuko Matsuda, Michelle McGovern, Robert T. Naismith, Akshata Ashokkumar, Janel Barnes, Dixie Ecklund, Elizabeth Klingner, Maxine Koepp, Jeffrey D. Long, Sneha Natarajan, Brenda Thornell, Jon Yankey, Robert Bermel, Josef P. Debbins, Xuemei Huang, Patricia Jagodnik, Mark J. Lowe, Kunio Nakamura, Sridar Narayanan, Ken E. Sakaie, Bhaskar Thoomukuntla, Xiaopeng Zhou, Stephen Krieger, Enrique Álvarez, Michelle Apperson, Khurram Bashir, Bruce A. Cohen, Patricia K. Coyle, Silvia Delgado, L. Dana DeWitt, Angela Flores, Barbara S. Giesser, Myla Goldman, Burk Jubelt, Neil Lava, Sharon Lynch, Harold L. Moses, Daniel Ontaneda, Jai Perumal, Michael K. Racke, Pavle Repovic, Claire Riley, Christopher Severson, Shlomo Shinnar, Valerie Suski, Bianca Weinstock-Guttman, Vijayshree Yadav, Aram Zabeti - New England Journal of Medicine 2018 被引用: 285

  11. Serum neurofilament light as a biomarker in progressive multiple sclerosis

    著者: Raju Kapoor, Kathryn E. Smith, Mark Allegretta, Douglas L. Arnold, William M. Carroll, Manuel Comabella, Roberto Furlan, Christopher Harp, Jens Kühle, David Leppert, Tatiana Plavina, Finn Sellebjerg, Caroline Sincock, Charlotte E. Teunissen, Ilir Topalli, Florian von Raison, Elizabeth Walker, Robert J. Fox - Neurology 2020 被引用: 153

  12. Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis

    著者: Steve Simpson-Yap, Edward De Brouwer, Tomas Kalincik, Nick Rijke, Jan A. Hillert, Clare Walton, Gilles Edan, Yves Moreau, Tim Spelman, Lotte Geys, Tina Parciak, Clement Gautrais, Nikola Lazovski, Ashkan Pirmani, Amin Ardeshirdavanai, Lars Forsberg, Anna Glaser, Robert McBurney, Hollie Schmidt, Arnfin B. Bergmann, Stefan Braune, Alexander Stahmann, Rodden Middleton, Amber Salter, Robert J. Fox, Anneke van der Walt, Helmut Butzkueven, Raed Alroughani, Serkan Ozakbas, Juan I. Rojas, Ingrid van der Mei, Nupur Nag, Rumen Ivanov, Guilherme Sciascia do Olival, Alice Estavo Dias, Melinda Magyari, Doralina Brum, Maria Fernanda Mendes, Ricardo N. Alonso, Richard S. Nicholas, Johana Bauer, Aníbal Sebastián Chertcoff, Anna Zabalza, Georgina Arrambide, Alexander Fidao, Giancarlo Comi, Liesbet Peeters - Neurology 2021 被引用: 238

  13. Long-term safety and efficacy of dimethyl fumarate for up to 13 years in patients with relapsing-remitting multiple sclerosis: Final ENDORSE study results

    著者: Ralf Gold, Douglas L. Arnold, Amit Bar‐Or, Robert J. Fox, Ludwig Kappos, Oksana Mokliatchouk, Xiaotong Jiang, Jennifer Lyons, Shivani Kapadia, Catherine Miller - Multiple Sclerosis Journal 2021 被引用: 75

  14. Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis

    著者: Patrick Vermersch, Luís Brieva, Robert J. Fox, Friedemann Paul, Lluís Ramió‐Torrentà, Matthias Schwab, Alain Moussy, Colin D. Mansfield, Olivier Hermine, Maciej Maciejowski, on behalf of the AB07002 Study Group, Nassima Hecham, Norma Deri, Jasminka Djelilović-Vranić, Ivan Milanov, Penko Shotekov, Gregg Blevins, J Girard, Yves Lapierre, William Camu, Giovanni Castelnovo, Pierre Clavelou, P. Hautecoeur, Martin Marziniak, Christoph Mayer, Patrick Oschmann, Gerd Reifschneider, I. Schoell, Björn Tackenberg, Florian Then Bergh, Ν. Fakas, Nikolaos Grigoriadis, D. Kalochristianakis, Dimos D. Mitsikostas, Anastasios Orologas, Antonios Tavernarakis, Thomas Thomaidis, Krisztina Kovács, K Mátyás, Pálma Piros, Mária Sátori, K.J.S. Anand, Alexander L. Shifrin, Krzysztof Banaszkiewicz, Robert Bonek, M. Chahwan, M. Czernichowska - Kotiuszko, Lidia Darda-Ledzion, J. D. Wojcik, M Dziki, Ewa Krzystanek, Marianna Kulka, Paweł Lisewski, Marcin Ratajczak, Andrzej Szczudlik, Jarosław Szczygieł, Małgorzata Pańczyk-Tomaszewska, Jacek Wójcik, Daniel Zielonka, M. Chiru, Swaroopa Deme, S Mănescu, S.A. Nica, Christian Popescu, Szabolcs Szatmári, A. L. Fedyanin, N A Malkova, D.V. Popov, Л. И. Волкова, Vorob'eva Ov, M Brozman, Andrea Cimprichová, P. Cuchran, Ladislav Gurcik, Georgi Krastev, I. Lisá, M. Nyeky, J. Poljaková, Peter Turčáni, Adaani Frost, Josef G. Heckmann, Eduardo Agüera, Francisco Coret, Antonio Escartín, Victoria Fernández, JR. Ara Callizo, Greg S. Martin, José Rodríguez, M. Martinez Gines, Daniel Muñoz, Javier Olascoaga, José M. Prieto, Cristina Ramo‐Tello, Samir Belal, S. Ben Ammou, Mahbouba Frih-Ayed, Riadh Gouider, Chokri Mhiri, Ridha Mrissa, Alla Cherkez ほか 21 名 - Neurology Neuroimmunology & Neuroinflammation 2022 被引用: 67

  15. Clinical trials for progressive multiple sclerosis: progress, new lessons learned, and remaining challenges

    著者: Jeremy Chataway, Thomas Williams, Vivien Li, Ruth Ann Marrie, Daniel Ontaneda, Robert J. Fox - The Lancet Neurology 2024 被引用: 63

  16. Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function

    著者: Daniel Ontaneda, Alan J. Thompson, Robert J. Fox, Jeffrey A. Cohen - The Lancet 2016 被引用: 295

  17. Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studies

    著者: Sreeja Gopal, Alvydas Mikulskis, Ralf Gold, Robert J. Fox, Katherine Dawson, Lakshmi Amaravadi - Multiple Sclerosis Journal 2017 被引用: 101

  18. Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients

    著者: Ranjan Dutta, Ansi Chang, Mary Kathryn Doud, Grahame J. Kidd, Michael V. Ribaudo, Elizabeth A. Young, Robert J. Fox, Susan M. Staugaitis, Bruce D. Trapp - Annals of Neurology 2010 被引用: 320

  19. Multiple sclerosis normal‐appearing white matter: Pathology–imaging correlations

    著者: Natalia Moll, Anna Rietsch, Smitha Thomas, Amy Ransohoff, Jar Chi Lee, Robert J. Fox, Ansi Chang, Richard M. Ransohoff, Elizabeth Fisher - Annals of Neurology 2011 被引用: 295

  20. Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients With Multiple Sclerosis

    著者: Robert J. Fox, Bruce Cree, J. de Sèze, Ralf Gold, Hans‐Peter Hartung, Douglas Jeffery, Ludwig Kappos, Xavier Montalbán, Bianca Weinstock‐Guttman, Carol M. Singh, Arman Altincatal, Nicholas Belviso, Robin L. Avila, Pei‐Ran Ho, Ray Su, Robert B. Engle, Dipen Sangurdekar, Carl de Moor, Elizabeth Fisher, Bernd C. Kieseier, Richard A. Rudick - Neurology 2024 被引用: 39

  21. Diet quality is associated with disability and symptom severity in multiple sclerosis

    著者: Kathryn C. Fitzgerald, Tuula Tyry, Amber Salter, Stacey S. Cofield, Gary Cutter, Robert J. Fox, Ruth Ann Marrie - Neurology 2017 被引用: 199

  22. Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial

    著者: Amit Bar‐Or, Peter A. Calabresi, Douglas L. Arnold, Clyde Markowitz, Stuart Shafer, Lloyd H. Kasper, Emmanuelle Waubant, Suzanne Gazda, Robert J. Fox, Michael Panzara, Neena Sarkar, Sunil Agarwal, Craig H. Smith - Annals of Neurology 2008 被引用: 530

  23. Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study

    著者: Bruce D. Trapp, Megan Vignos, Jessica Dudman, Ansi Chang, Elizabeth Fisher, Susan M. Staugaitis, Harsha Battapady, Sverre Mørk, Daniel Ontaneda, Stephen E. Jones, Robert J. Fox, Jacqueline Chen, Kunio Nakamura, Richard A. Rudick - The Lancet Neurology 2018 被引用: 145

  24. Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis

    著者: Jeffrey A. Cohen, Peter B. Imrey, Sarah M. Planchon, Robert Bermel, Elizabeth Fisher, Robert J. Fox, Amit Bar‐Or, Susan L Sharp, Thomai T Skaramagas, Patricia Jagodnik, Matt Karafa, Shannon L. Morrison, Jane Reese Koç, Stanton L. Gerson, Hillard M. Lazarus - Multiple Sclerosis Journal 2017 被引用: 119